Abstract
Introduction Characterization of HIV risk factors among transwomen and men who have sex with men (MSM) should be assessed separately and independently. However, due to several constraints, these populations continue to be conflated in clinical research and data. There are limited datasets globally powered to make such comparisons. The study aimed to use one of the largest surveys of transwomen and MSM in Latin America to determine differences in HIV risk and related correlates between the two populations.
Methods Secondary data analysis was completed using a cross-sectional biobehavioral survey of 4413 MSM and 714 transwomen living in Perú. Chi Square analysis of selected HIV correlates was conducted to examine differences between transwomen and MSM. Additionally, stratified binary logistic regression was used to split data for further comparative analyses of correlates associated with transwomen and MSM separately.
Results HIV prevalence among transwomen was two-fold greater than among MSM (14.9% vs. 7.0%, p<0.001). Transwomen had a higher prevalence of most HIV risk factors assessed, including presence of alcohol dependence (16.4% vs. 19.0%; p<.001) and drug use in the past 3 months (17.0% vs. 14.9%). MSM were more likely to use marijuana (68.0% vs. 50.0%, p<.001), and transwomen were more likely to engage in inhaled cocaine use (70.0% vs. 51.1%, p<.001). The regression exposed differences in correlates driving sub-epidemics in transwomen vs. MSM, with a trend of substance use increasing HIV risk for transwomen only.
Conclusions Transwomen were more likely to be HIV-infected and had different risk factors from MSM. Targeted prevention strategies are needed for transwomen that are at highest risk. Additionally, further research is needed to determine if these observations in Perú regarding substance use patterns and the role of substance use in HIV risk relate to other trans populations globally.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Institute on Drug Abuse (NIDA) at the National Institutes of Health, The Loan Repayment Program at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the Fogarty International Center
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Yale University gave ethical approval for this work. IRB of Asociacion Civil Impacta Salud y Educacion Peru gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
EC: elena.cyrus{at}ucf.edu
JRL: jrlama{at}impactaperu.org
JS: jsanchez{at}citbm.pe
SL: segundo.leon{at}upsjb.edu.pe
MVV: mvillar2{at}fredhutch.org
PV: pvagenas{at}berkeley.edu
DSS: dannysullivan{at}knights.ucf.edu
DV: dvu140{at}knights.ucf.edu
MC: makella.coudray{at}ucf.edu
FLA: frederick.altice{at}yale.edu
Author order was corrected.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
